SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Slugger who wrote (7648)11/5/1998 9:33:00 AM
From: Robert K.  Respond to of 17367
 
From the xoma site>
>November '98

3Q Financials / 10Q Filing
12-13, Berkeley, CA

Infectious Diseases Society of America
12-15, Denver, CO

<Picture>Steven Opal, Brown University, School of Medicine, Providence, RI; Patrick J. Scannon, MD, PhD, "The Interaction of LPS-Binding Protein (LBP) and Endotoxin as Determinants of Outcome in Severe Sepsis"

National Association of Stockbrokers (NAS)
12-13, Atlanta, GA; Orlando, FL
<Picture>Jack Castello, CEO, XOMA Corporate Presentation

Taipan Annual Investors Meeting
15, Clearwater, FL
<Picture>Jack Castello, CEO, XOMA Corporate Presentation

American Society of Pharmaceutical Scientists (AAPS)
16-19, San Francisco, CA
<Picture>Robert Bauer, PhD, "Pharmacokinetics and Pharmacodynamics of hu1124 in Psoriasis"